"Botanix also continues to actively explore other opportunities for its synthetic cannabidiol and novel cannabinoid analog
development assets. These include addressing other bacterial infections, enabling different routes of drug administration, and synthesizing new cannabinoids with improved bioavailability and potency."
Do throw us some more hints Mr V where you are testing our Mortein on ??
If 1801 is a winner BOT could finally be the Pfizer of 2020..
Ann: Appendix 4C - Quarterly, page-13
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
43.5¢ |
Change
0.020(4.82%) |
Mkt cap ! $789.1M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 44.0¢ | 41.5¢ | $2.952M | 6.862M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 360560 | 43.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.5¢ | 50036 | 4 |
View Market Depth
| Last trade - 14.15pm 09/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |